A Phase I/II Study of CP-4055 in Patients With Platinum Resistant Ovarian Cancer
Clinical trial NCT00831636 · COMPLETED
Trial details
- NCT number
- NCT00831636
- Sponsor
- Clavis Pharma
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-01
- Primary completion
- 2009-11-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.